4.6 Article

VRK3 depletion induces cell cycle arrest and metabolic reprogramming of pontine diffuse midline glioma-H3K27 altered cells

Related references

Note: Only part of the references are listed.
Article Oncology

Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas

Justyna M. Przystal et al.

Summary: The imipridone ONC201 and its derivative ONC206 significantly reduce cell viability in pediatric diffuse midline gliomas (DMGs) and prolong the survival of DMG PDX models. Both drugs impair tumor cell growth and survival by activating mitochondrial metabolism and the integrative stress response (ISR), and trigger cell lineage differentiation. These findings are of great importance for the treatment of pediatric DMGs.

NEURO-ONCOLOGY (2022)

Article Oncology

Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma

Trang T. T. Nguyen et al.

Summary: A novel synthetic lethal interaction between ClpP activation and HDAC1/2 inhibition has been identified to impact the energy metabolism of glioblastoma (GBM). The combined treatment of ClpP activators and HDAC inhibitors shows promise in significantly reducing GBM cell viability and prolonging host survival.

CLINICAL CANCER RESEARCH (2022)

Article Oncology

VRK1 Is a Synthetic-Lethal Target in VRK2-Deficient Glioblastoma

Julie A. Shields et al.

Summary: Synthetic lethality between paralog genes VRK1 and VRK2 plays a crucial role in treating VRK2-deficient glioblastoma.

CANCER RESEARCH (2022)

Article Medicine, Research & Experimental

VRK1 as a synthetic lethal target in VRK2 promoter-methylated cancers of the nervous system

Jonathan So et al.

Summary: Collateral lethality occurs when loss of a gene/protein renders cancer cells dependent on its remaining paralog. This study identified VRK1 as a synthetic lethal target in VRK2 promoter-methylated adult and pediatric gliomas and neuroblastomas. Depletion of VRK1 led to DNA damage and apoptosis due to reduced phosphorylation of the barrier-to-autointegration factor during mitosis.

JCI INSIGHT (2022)

Article Oncology

Epidermal growth factor receptor as a molecular determinant of glioblastoma response to dopamine receptor D2 inhibitors

Yuyu He et al.

Summary: The study revealed that high EGFR expression is a determinant of poor glioblastoma response to DRD2 inhibition. This finding should be taken into consideration for future clinical trial designs.

NEURO-ONCOLOGY (2021)

Article Biotechnology & Applied Microbiology

PFKFB4 Overexpression Facilitates Proliferation by Promoting the G1/S Transition and Is Associated with a Poor Prognosis in Triple-Negative Breast Cancer

Yu-Chen Cai et al.

Summary: PFKFB4 overexpression is associated with unfavorable prognosis in TNBC, promoting tumor progression by enhancing G1/S phase transition through increasing CDK6 protein levels and Rb phosphorylation.

DISEASE MARKERS (2021)

Article Medicine, Research & Experimental

E2F2 drives glioma progression via PI3K/AKT in a PFKFB4-dependent manner

Longzhou Zhang et al.

Summary: The study elucidated that E2F2 plays a crucial role in glioma malignancy progression by transcriptionally enhancing PFKFB4 expression and activating the PI3K/AKT pathway. Inhibition of E2F2 suppressed glioma growth and metastasis, indicating its potential as a therapeutic target.

LIFE SCIENCES (2021)

Article Genetics & Heredity

Comprehensive molecular characterization of mitochondrial genomes in human cancers

Yuan Yuan et al.

NATURE GENETICS (2020)

Article Medicine, Research & Experimental

HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models

Trang Thi Thu Nguyen et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Biochemistry & Molecular Biology

A unified model for the G1/S cell cycle transition

Samuel Hume et al.

NUCLEIC ACIDS RESEARCH (2020)

Article Biochemistry & Molecular Biology

H3S10ph broadly marks early-replicating domains in interphase ESCs and shows reciprocal antagonism with H3K9me2

Carol C. L. Chen et al.

GENOME RESEARCH (2018)

Article Biochemistry & Molecular Biology

VRK1 and AURKB form a complex that cross inhibit their kinase activity and the phosphorylation of histone H3 in the progression of mitosis

David S. Moura et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2018)

Review Biochemistry & Molecular Biology

Implication of the VRK1 chromatin kinase in the signaling responses to DNA damage: a therapeutic target?

Ignacio Campillo-Marcos et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2018)

Article Multidisciplinary Sciences

DNA methylation-based classification of central nervous system tumours

David Capper et al.

NATURE (2018)

Article Pathology

High expression of VRK1 is related to poor prognosis in glioma

Zhiyun Ben et al.

PATHOLOGY RESEARCH AND PRACTICE (2018)

Article Multidisciplinary Sciences

Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer

Subhamoy Dasgupta et al.

NATURE (2018)

Article Cell Biology

VRK2A is an A-type lamin-dependent nuclear envelope kinase that phosphorylates BAF

K. C. Birendra et al.

MOLECULAR BIOLOGY OF THE CELL (2017)

Article Biochemistry & Molecular Biology

Comparative Interactomes of VRK1 and VRK3 with Their Distinct Roles in the Cell Cycle of Liver Cancer

Namgyu Lee et al.

MOLECULES AND CELLS (2017)

Review Biochemistry & Molecular Biology

Mitochondria and Cancer

Sejal Vyas et al.

Article Biochemistry & Molecular Biology

Presumed pseudokinase VRK3 functions as a BAF kinase

Choon-Ho Park et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)

Article Clinical Neurology

Biopsy in a series of 130 pediatric diffuse intrinsic Pontine gliomas

Stephanie Puget et al.

CHILDS NERVOUS SYSTEM (2015)

Article Medicine, General & Internal

VRK2 identifies a subgroup of primary high-grade astrocytomas with a better prognosis

Irene Rodriguez-Hernandez et al.

BMC CLINICAL PATHOLOGY (2013)

Article Multidisciplinary Sciences

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

Jeremy Schwartzentruber et al.

NATURE (2012)

Review Oncology

Otto Warburg's contributions to current concepts of cancer metabolism

Willem H. Koppenol et al.

NATURE REVIEWS CANCER (2011)

Article Biochemistry & Molecular Biology

Plk3 Interacts with and Specifically Phosphorylates VRK1 in Ser342, a Downstream Target in a Pathway That Induces Golgi Fragmentation

Inmaculada Lopez-Sanchez et al.

MOLECULAR AND CELLULAR BIOLOGY (2009)

Review Multidisciplinary Sciences

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

Matthew G. Vander Heiden et al.

SCIENCE (2009)

Article Multidisciplinary Sciences

Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

Ralph J. DeBerardinis et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Biochemistry & Molecular Biology

Mitotic histone H3 phosphorylation by vaccinia-related kinase 1 in mammalian cells

Tae-Hong Kang et al.

MOLECULAR AND CELLULAR BIOLOGY (2007)

Article Biochemistry & Molecular Biology

Identification of a dominant epitope in human vaccinia-related kinase 1 (VRK1) and detection of different intracellular subpopulations

Alberto Valbuena et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)